Projects per year
Personal profile
Education/Academic qualification
Doctor of Philosophy, doctorate, University of Lucknow
Fingerprint
Dive into the research topics where Manoj Pandey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
Targeting Therapy-Resistant Multiple Myeloma with a Novel Pan ALDH Inhibitor: A New Frontier in Overcoming Relapse
Pandey, M. (PI)
New Jersey Health Foundation, Inc. (NJHF)
2/17/25 → 2/16/26
Project: Other project
-
Novel Mcl-1 Inhibitor for Combination Treatment of Refractory Multiple Myeloma
Pandey, M. (PI)
National Institutes of Health (NIH)
8/5/24 → 6/30/27
Project: Other project
-
Novel Targeted Therapy for Refractory Multiple Myeloma
Pandey, M. (PI)
National Institutes of Health (NIH)
5/1/24 → 4/30/28
Project: Other project
-
The Study of Small RNA Sequencing from Biological Samples (miRNA-seq)
Elbezanti, W. O., Challagundla, K. B. & Pandey, M. K., 2025, Methods in Molecular Biology. Humana Press Inc., p. 175-188 14 p. (Methods in Molecular Biology; vol. 2866).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients
Al-Odat, O. S., Nelson, E., Budak-Alpdogan, T., Jonnalagadda, S. C., Desai, D. & Pandey, M. K., Jul 2024, In: Cancers. 16, 13, 2381.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?
Motlak, M., Mathews, M., Al-Odat, O. S. & Pandey, M. K., Jul 2024, In: Cytokine. 179, 156629.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis
Al-Odat, O. S., Elbezanti, W. O., Gowda, K., Srivastava, S. K., Amin, S. G., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M. K., 2024, In: Frontiers in Pharmacology. 15, 1436786.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
Bhowmick, K., von Suskil, M., Al-Odat, O. S., Elbezanti, W. O., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M. K., Jun 30 2024, In: Heliyon. 10, 12, e33091.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations